Eva Domingo-Domenech Selected Research

Eva Domingo-Domenech Research Topics

Disease

9	Lymphoma (Lymphomas) 10/2022 - 04/2003
7	Neoplasms (Cancer) 01/2021 - 06/2011
4	Hodgkin Disease (Hodgkin's Disease) 12/2021 - 09/2016
3	Infections 06/2019 - 06/2004
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 10/2017 - 11/2009
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2022 - 01/2019
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2022 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 11/2020 - 11/2004
2	Neutropenia 06/2019 - 04/2012
1	Pathologic Complete Response 04/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Febrile Neutropenia 06/2019
1	Hyperthyroidism 01/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2017
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016
1	Disease Progression 06/2015
1	HIV Infections (HIV Infection) 06/2015
1	Bacteremia 03/2014
1	Lymphadenopathy 10/2012
1	Inflammation (Inflammations) 04/2012
1	Felty Syndrome (Syndrome, Felty's) 04/2012
1	Bacterial Infections (Bacterial Infection) 04/2012
1	Arthritis (Polyarthritis) 04/2012
1	Reinfection 04/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 06/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2011
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2007
1	Pain (Aches) 10/2005
1	Oncogenic osteomalacia 10/2005
1	Hypophosphatemia 10/2005
1	Hypersensitivity (Allergy) 11/2004
1	Asthma (Bronchial Asthma) 11/2004

Drug/Important Bio-Agent (IBA)

9	Rituximab (Mabthera)FDA Link 04/2021 - 11/2007
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 01/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 01/2016
3	Prednisone (Sone)FDA LinkGeneric 10/2022 - 01/2016
3	Vincristine (Oncovin)FDA LinkGeneric 10/2022 - 01/2016
2	Brentuximab VedotinIBA 12/2021 - 01/2019
2	Pharmaceutical PreparationsIBA 01/2019 - 03/2014
2	Bendamustine Hydrochloride FDA Link 10/2017 - 12/2014
2	fludarabineIBA 04/2017 - 11/2009
2	Biological ProductsIBA 04/2012 - 03/2011
2	Biomarkers (Surrogate Marker)IBA 04/2012 - 06/2011
2	AntibodiesIBA 06/2004 - 04/2003
2	EnzymesIBA 06/2004 - 04/2003
1	Immunoconjugates (Immunoconjugate)IBA 12/2021
1	daratumumabIBA 01/2021
1	carfilzomibIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Anaplastic Lymphoma KinaseIBA 01/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	pembrolizumabIBA 11/2020
1	AFM13IBA 11/2020
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2019
1	Monoclonal AntibodiesIBA 01/2019
1	NivolumabIBA 01/2019
1	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2017
1	ofatumumab FDA Link 09/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2014
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2012
1	Antirheumatic Agents (DMARD)IBA 04/2012
1	pro-brain natriuretic peptide (1-76)IBA 06/2011
1	Phosphates (Orthophosphate)IBA 10/2005
1	Calcitriol (Calcijex)FDA LinkGeneric 10/2005
1	Hair DyesIBA 10/2005
1	Immunoglobulin E (IgE)IBA 11/2004
1	LatexIBA 11/2004
1	ORALIT (ORS)IBA 11/2004
1	hydroxide ionIBA 06/2004
1	Immunoglobulin G (IgG)IBA 06/2004

Therapy/Procedure

9	Therapeutics 10/2022 - 11/2007
4	Drug Therapy (Chemotherapy) 06/2019 - 06/2011
2	Cell Transplantation 01/2021 - 06/2015
1	Radiotherapy 01/2021
1	Immunotherapy 11/2020
1	Salvage Therapy 09/2016
1	Chemoradiotherapy 06/2015
1	Urinary Catheters 03/2014
1	Biological Therapy 04/2012
1	Retreatment 04/2012
1	Organ Transplantation 11/2007